RIM
AZN icon

Ranger International Management’s AstraZeneca AZN Stock Holding History

Ranger International Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-186,758
Closed -$12.1M – 60
2014
Q1 		$12.1M Sell
186,758
-2,090
-1% -$135K 3.85% 12
2013
Q4 		$11.2M Hold
188,848
– – 3.98% 13
2013
Q3 		$9.81M Buy
188,848
+4,200
+2% +$211K 4.01% 10
2013
Q2 		$8.73M Buy
+184,648
New +$9.4M 3.54% 17

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ranger International Management's AZN Position: Q2 2014 in Review

Ranger International Management sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 186,758 shares — an estimated $12.1M sold.

Ranger International Management first reported a position in AZN in Q2 2013 and held it in 4 quarters. The position peaked at $12.1M in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

  • Ranger International Management reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
  • Ranger International Management sold 186,758 AstraZeneca shares in Q2 2014, an estimated $12.1M.
  • Ranger International Management first reported a position in AstraZeneca in Q2 2013 and held it in 4 quarters.
  • Ranger International Management's AstraZeneca position peaked at $12.1M in Q1 2014.
  • 419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Ranger International Management's 13F filing for Q2 2014, filed 14 Aug 2014.